Registered entities
Amolyt Pharma, Inc.
Reg. No. 320614623United States
Innovation
3 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 92 times.
| Year | Filings |
|---|---|
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2025 | 1 |
Investor mix
25 investors on record; lead investors include Sectoral, Andera Partners, Life Sciences Partners, Sofinnova Partners; 7 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 36% |
| Private equity | 7 | 28% |
| Bank & private debt | 2 | 8% |
| Other / undisclosed | 7 | 28% |